NeurobiologyNeurosciencePharmacology

AMPA Receptor: Engine of Synaptic Plasticity

A comprehensive scholarly reference guide to the AMPA receptor: detailing its biophysical properties, molecular subunit composition, RNA editing, synaptic trafficking mechanisms, and clinical significance in fast excitatory neurotransmission and synaptic plasticity.

memjavad
PUBLISHED
Scientifically Reviewed · Dr. Marwa Abd-Alazim · October 7, 2026
Medically & Scientifically Reviewed Verified: October 7, 2026
Dr. Marwa Abd-Alazim Ph.D.
Professor of Psychology • University of Kerbala
Review Criteria & Clinical Standards

This content undergoes rigorous scientific peer-review and medical editorial standards at Arab Psychology Network to ensure clinical accuracy, validity, and compliance with evidence-based guidelines from leading psychological and healthcare authorities (APA / WHO).

Fast excitatory neurotransmission across mammalian central nervous systems relies fundamentally on the rapid, millisecond-scale kinetics of ionotropic glutamate receptors. Among these, the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor, universally designated as the AMPA receptor, serves as the primary molecular conduit for baseline synaptic communication, cognitive processing, and adaptive synaptic modification.

AMPA Receptor

1. Concise Definition

The AMPA receptor (AMPAR) is a subtype of ionotropic transmembrane glutamate receptor that mediates the vast majority of fast excitatory synaptic transmission throughout the vertebrate central nervous system. As a ligand-gated ion channel, it opens transiently upon binding the endogenous neurotransmitter L-glutamate, permitting the inward flux of monovalent cations such as sodium (Na+) and, in specific subunit assemblies, divalent calcium (Ca2+).

Structurally organized as a homo- or heterotetramer composed of four distinct subunits (GluA1 through GluA4), the AMPA receptor orchestrates immediate post-synaptic depolarization. Its dynamic insertion into and retrieval from the postsynaptic density constitutes the primary biophysical substrate for long-term potentiation and long-term depression, rendering it indispensable for learning, memory consolidation, and network-level neuroplasticity.

2. Etymology & Linguistic Origin

The term “AMPA receptor” derives eponymously from its selective, high-affinity synthetic agonist, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (abbreviated as AMPA). The chemical nomenclature combines classical Greek and modern systematic chemical roots: alpha (α), denoting the primary carbon position; amino (from ammonia, ultimately traced to the Egyptian deity Ammon, near whose temple sal ammoniac was gathered); hydroxy (blending Greek hydōr, water, and oxys, sharp or acidic); methyl (from Greek methy, wine, and hylē, wood); isoxazole (denoting the five-membered heterocyclic ring containing oxygen and nitrogen); and propionic (from Greek prōtos, first, and piōn, fat, referencing the simplest fatty acid). The noun receptor originates from the Latin recipere (“to receive” or “take back”), compounded from re- (again, back) and capere (to take or seize).

3. Pronunciation & Grammatical Form

Pronunciation: Phonetically transcribed as /ˈæm.pə rɪˈsɛp.tər/ (AM-puh rih-SEP-ter).

Grammatical Form: Count noun, compound nominal phrase. Plural form: AMPA receptors (or AMPARs). In molecular genetics and neurobiology, it is frequently used attributively to modify related anatomical and functional entities, such as “AMPA receptor subunit,” “AMPA receptor trafficking,” or “AMPA receptor-mediated current.”

4. Detailed Conceptual Explanation

The AMPA receptor occupies a central position in cellular neuroscience as the principal gatekeeper of fast synaptic excitation. In the central nervous system, communication between presynaptic axonal boutons and postsynaptic dendritic spines depends upon the rapid exocytosis of glutamate into the synaptic cleft. Upon traversing this intercellular gap—typically measuring 20 nanometers—glutamate molecules bind to the extracellular ligand-binding domain (LBD) of postsynaptic AMPA receptors. This binding event initiates an almost instantaneous conformational rearrangement that opens the integral channel pore, driving rapid membrane depolarization through the inward flow of sodium ions driven by a strong electrochemical gradient.

The functional architecture of the native AMPA receptor is modular, consisting of four distinct structural layers: the extracellular amino-terminal domain (ATD), the ligand-binding domain (LBD), the transmembrane domain (TMD), and the intracellular carboxyl-terminal domain (CTD). The transmembrane domain encompasses three membrane-spanning alpha helices (M1, M3, and M4) alongside a re-entrant pore loop (M2) that lines the ion-conduction channel and dictates its elemental selectivity. Channel opening occurs within sub-millisecond timescales, and receptor deactivation or desensitization unfolds over a span of two to ten milliseconds, making AMPA receptors uniquely suited to preserve the temporal fidelity of high-frequency neuronal spiking.

A critical determinant of AMPA receptor biophysics is the post-transcriptional enzymatic editing of messenger RNA, particularly at the glutamine/arginine (Q/R) editing site of the GluA2 subunit. Catalyzed by the enzyme ADAR2 (adenosine deaminase acting on RNA 2), this editing process swaps an uncharged glutamine residue for a positively charged arginine within the channel pore loop. The presence of this positively charged arginine introduces an electrostatic barrier that renders heterotetrameric GluA2-containing AMPA receptors virtually impermeable to calcium ions, linearizes their current-voltage relationship, and protects neurons from excitotoxic injury. Conversely, AMPA receptors lacking edited GluA2—frequently termed calcium-permeable AMPA receptors (CP-AMPARs)—exhibit high calcium conductivity and are subject to voltage-dependent blockade by endogenous intracellular polyamines such as spermine.

Beyond the core pore-forming tetramers, native AMPA receptors do not operate in molecular isolation; they exist as macromolecular complexes tightly integrated with auxiliary subunits. These include transmembrane AMPA receptor regulatory proteins (TARPs, such as stargazin/γ-2), cornichon homologs (CNIH-2 and CNIH-3), and germ cell-specific gene 1-like protein (GSG1L). These auxiliary proteins modulate channel kinetics, slow desensitization and deactivation rates, regulate ion permeation, and tether the receptor complex to sub-membranous scaffolding proteins such as PSD-95. This macromolecular assembly ensures that AMPA receptors are properly localized within the active zone nano-domains directly opposing presynaptic release machinery.

5. Historical Development

The discovery and conceptual delineation of AMPA receptors evolved through pharmacological and molecular breakthroughs that unraveled the mechanisms of excitatory amino acid neurotransmission:

  • 1970s (Pharmacological Differentiation): Early neuropharmacologists, led by Jeff Watkins and colleagues, demonstrated that L-glutamate and L-aspartate activated multiple distinct receptor classes in the mammalian spinal cord. By synthesizing structural analogues, Watkins isolated responses sensitive to N-methyl-D-aspartate (NMDA receptor) from non-NMDA responses.
  • 1980 (Synthesis of AMPA): Tage Honoré, Lauridsen, and Krogsgaard-Larsen synthesized the heterocyclic isoxazole derivative α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA). This compound acted as a selective and potent agonist for the non-NMDA receptor population, separating AMPA-sensitive sites from kainate-sensitive sites.
  • 1989–1992 (Molecular Cloning): The molecular revolution in glutamate receptor biology accelerated when Michael Hollmann, Stephen Heinemann, and colleagues successfully isolated and cloned the first cDNA encoding a functional glutamate receptor subunit (initially termed GluR-K1, later renamed GluA1). Subsequent work by Peter Seeburg and colleagues identified GluA2, GluA3, and GluA4, discovering alternative splicing pathways (flip/flop variants) and post-transcriptional RNA editing.
  • Late 1990s to 2000s (Receptor Trafficking and TARPs): Research led by Roberto Malinow, Robert Malenka, and Roger Nicoll illuminated the dynamic exocytosis, endocytosis, and lateral diffusion of AMPA receptors during synaptic plasticity. Concurrently, the identification of stargazin as the founding member of TARPs established the paradigm that auxiliary subunits dictate receptor localization and biophysics.
  • 2009–Present (Structural Resolution): Eric Gouaux and collaborators resolved the full-length crystal and cryo-electron microscopy (cryo-EM) structures of the GluA2 tetramer. These structural models visualized the Y-shaped, domain-swapped tetrameric architecture and revealed the atomic transitions that occur between resting, active, and desensitized states.

6. Theoretical Foundations

The study of AMPA receptors is grounded in classical biophysical cable theory and the Hebbian theory of synaptic plasticity. Donald Hebb’s 1949 postulate—that coordinated and repeated pre- and postsynaptic activation strengthens synaptic efficacy—found its biological substrate in the functional coordination between AMPA and NMDA receptors.

Under baseline resting conditions, the neuronal membrane sits near -70 millivolts. Although glutamate release binds both receptor types, the NMDA receptor channel pore remains blocked by extracellular magnesium (Mg2+) ions. AMPA receptors lack this voltage-sensitive block at resting potentials, allowing them to rapidly transduce glutamate binding into a fast depolarizing current (the excitatory postsynaptic potential, or EPSP). When high-frequency or synchronized inputs generate robust AMPA receptor-driven depolarization, this change in membrane potential expels the Mg2+ ion from the NMDA receptor pore via electrostatic repulsion. The resulting influx of calcium through NMDA receptors triggers intracellular signaling cascades, notably activating Ca2+/calmodulin-dependent protein kinase II (CaMKII).

The recruitment of CaMKII establishes the framework for Long-Term Potentiation (LTP). CaMKII phosphorylates GluA1 subunits (for example, at Serine 831) to increase single-channel conductance, while simultaneously triggering the mobilization of reserve AMPA receptors from intracellular endosomal compartments to the extrasynaptic membrane. Through lateral diffusion, these newly mobilized receptors are captured and immobilized at the postsynaptic density by scaffolding proteins. Conversely, low-frequency stimulation drives Long-Term Depression (LTD) through calcineurin- and protein phosphatase 1-dependent dephosphorylation (such as Serine 845), triggering clathrin-mediated endocytosis of AMPA receptors. Thus, the insertion, lateral stabilization, and endocytic removal of AMPA receptors serve as the physical expression of Hebbian synaptic modifications.

7. Key Components, Types & Dimensions

AMPA receptors display structural and functional diversity governed by genetic identity, subunit stoichiometry, post-transcriptional editing, and alternative splicing:

  • Pore-Forming Subunits (GluA1–GluA4): Encoded by the human gene family GRIA1, GRIA2, GRIA3, and GRIA4. GluA1, GluA2, and GluA3 are abundant throughout the adult hippocampus and cerebral cortex, whereas GluA4 is predominantly expressed during early neurodevelopment and in specialized adult populations, such as cerebellar granule cells and auditory relay interneurons.
  • Subunit Stoichiometry: Functional channels exist as dimers of dimers assembled into a tetrameric complex. While homomeric channels can form in experimental systems, native forebrain receptors are overwhelmingly heteromeric, primarily configured as GluA1/GluA2 or GluA2/GluA3 assemblies.
  • RNA Editing (Q/R and R/G Sites): The enzymatic modification of GluA2 pre-mRNA replaces glutamine with arginine at position 607 within the pore loop (Q/R site), conferring Ca2+ impermeability and resistance to polyamine blockade. A separate editing event at the R/G site (preceding the alternative splicing domain) accelerates recovery rates from desensitization.
  • Flip and Flop Splicing Modules: An alternative splice cassette of 38 amino acids, situated in the extracellular loop between transmembrane domains M3 and M4, produces either the “flip” or “flop” splice variant. Flip variants show slower desensitization kinetics and sustained currents in response to glutamate, whereas flop variants desensitize more rapidly and thoroughly.
  • Auxiliary Subunits: Auxiliary proteins associate alongside the core tetramer to shape native channel behavior:
    • TARPs (Type I: γ-2/stargazin, γ-3, γ-4, γ-8; Type II: γ-5, γ-7): Enhance surface expression, increase channel open probability, slow deactivation, and mediate synaptic clustering.
    • Cornichon Homologs (CNIH-2, CNIH-3): Slow both desensitization and deactivation kinetics while boosting surface trafficking.
    • SynDIG1, GSG1L, and CKAMP44: Modulate desensitization kinetics, recovery cycles, and distinct pharmacology across regional brain circuits.

8. Examples & Illustrative Cases

The diverse functional roles of AMPA receptors are evident across specialized circuits in the central nervous system:

  • Hippocampal CA1 Pyramidal Neurons: In classical Schaffer collateral-CA1 pyramidal synapses, the resting postsynaptic density contains a mix of heteromeric GluA1/GluA2 and GluA2/GluA3 receptors. During spatial navigation learning, high-frequency stimulation triggers CaMKII activation, driving the rapid synaptic insertion of GluA1-containing receptors. This physical increase in receptor density elevates the amplitude of the recorded EPSP, stabilizing the memory trace for local place fields.
  • Auditory Brainstem Relay Neurons: Neurons within the calyx of Held synapse require exceptional temporal precision to calculate interaural time differences for sound localization. These specialized synapses express AMPA receptors enriched with GluA4 flop variants and auxiliary proteins that accelerate channel kinetics. The channels activate and desensitize in sub-millisecond timeframes, preventing temporal smearing and allowing high-frequency acoustic impulses to be transmitted with microsecond fidelity.
  • Cerebellar Purkinje Cells: Purkinje cells express high levels of GluA2 and GluA3 alongside the auxiliary subunit TARP γ-2 (stargazin). In the stargazer mutant mouse, a defect in the CACNG2 gene disrupts stargazin expression, preventing AMPA receptors from reaching the postsynaptic membrane of cerebellar granule cells. This trafficking failure causes severe ataxia and absence epilepsy, demonstrating that auxiliary subunit-mediated localization is essential for intact motor coordination.

9. Measurement & Assessment

Investigating AMPA receptor function, pharmacology, and biophysics relies on a combination of electrophysiological, imaging, and biochemical methodologies:

  • Electrophysiology (Whole-Cell and Outside-Out Patch Clamp): The patch-clamp technique provides high-resolution data on AMPA receptor behavior. Whole-cell recordings track spontaneous, miniature, and evoked excitatory postsynaptic currents (EPSCs). Outside-out patches exposed to ultrafast piezoelectric application of glutamate allow researchers to measure single-channel conductance (typically 9 to 28 picosiemens), open probability, deactivation times, and microscopic desensitization rates.
  • Pharmacological Isolation: AMPA currents are experimentally separated from other electrical activity using selective antagonists. Researchers block NMDA receptors with D-AP5 or MK-801, inhibitory GABAA receptors with picrotoxin or bicuculline, and kainate receptors with selective modulators. To selectively silence AMPA receptors, classical quinoxalinediones like NBQX and CNQX, or non-competitive antagonists such as perampanel and GYKI 52466, are applied.
  • Two-Photon Glutamate Uncaging: Combining two-photon laser microscopy with chemically caged glutamate (such as MNI-caged L-glutamate) enables researchers to map functional AMPA receptors on individual dendritic spines. Delivering localized laser flashes releases active glutamate, allowing direct quantification of local spine sensitivity without confounding presynaptic effects.
  • Structural Cryo-Electron Microscopy (Cryo-EM): High-resolution single-particle cryo-EM provides detailed structural maps of AMPA receptor tetramers complexed with auxiliary proteins, agonists, competitive antagonists, and allosteric modulators. These structural snapshots delineate the conformational steps of channel gating and desensitization at near-atomic resolution.
  • Biochemical Surface Biotinylation and Western Blotting: To differentiate between intracellular and plasma membrane-bound pools of AMPAR subunits, researchers apply membrane-impermeant biotinylation reagents to live slices or primary neuronal cultures. Following cell lysis and streptavidin pull-down, western blotting quantifies subunit surface expression changes during LTP or LTD protocols.

10. Applications & Practical Significance

Given their primary role in excitatory neurotransmission, AMPA receptors are critical therapeutic targets and diagnostic markers in clinical neuroscience, neurology, and psychiatry:

  • Epilepsy Pharmacotherapy: Excessive, synchronous AMPA receptor-mediated excitation is a primary driver of epileptic seizure generation and spread. The pharmaceutical agent perampanel acts as a selective, non-competitive allosteric antagonist at AMPA receptors. By dampening baseline excitatory transmission, perampanel functions as an effective antiepileptic drug for focal-onset and primary generalized tonic-clonic seizures.
  • Cognitive Enhancement and Ampakines: Positive allosteric modulators (PAMs) of AMPA receptors, commonly referred to as ampakines (such as CX-516, CX-717), bind allosteric pockets within the ligand-binding domain dimer interface. These compounds slow desensitization and deactivation without directly opening the pore. Ampakines prolong excitatory postsynaptic potentials and enhance downstream BDNF transcription, making them candidates for treating cognitive deficits in schizophrenia, Alzheimer’s disease, and attention-deficit/hyperactivity disorder (ADHD).
  • Excitotoxicity and Neuroprotection: During acute ischemic stroke or traumatic brain injury, the loss of cellular energy homeostasis triggers excessive presynaptic glutamate release. Calcium-permeable AMPA receptors (CP-AMPARs)—frequently unmasked when ischemia reduces GluA2 transcription or activity—allow massive Ca2+ influx. This calcium overload activates calpains, generates reactive oxygen species, and initiates apoptotic cascades. Blocking CP-AMPARs remains a targeted strategy for neuroprotection in stroke.
  • Autoimmune Encephalitis: Anti-AMPA receptor encephalitis is a severe autoimmune disorder characterized by pathogenic autoantibodies directed against the extracellular epitopes of GluA1 or GluA2 subunits. This antibody binding triggers rapid receptor cross-linking and internalizing endocytosis. Patients present with acute limbic encephalitis, fulminant memory loss, confusion, and refractory seizures, requiring aggressive treatment with plasma exchange, intravenous immunoglobulins, and corticosteroids.
  • Amyotrophic Lateral Sclerosis (ALS): Motor neurons are uniquely vulnerable to excitotoxicity because they express low endogenous levels of the GluA2 subunit and frequently exhibit deficient ADAR2-mediated RNA editing. The resulting excess of calcium-permeable AMPA receptors contributes to selective motor neuron degeneration in ALS, highlighting AMPA receptor modulation as an active area of neuroprotective research.

11. Research & Empirical Evidence

Decades of empirical studies have solidified our understanding of AMPA receptor biophysics and their role in dynamic neural circuitry:

  • Silent Synapses and Synaptogenesis: Seminal patch-clamp studies conducted in the mid-1990s by Isaac, Malenka, and Nicoll revealed the presence of “silent synapses” in the neonatal hippocampus. These immature connections contain functional postsynaptic NMDA receptors but completely lack membrane-bound AMPA receptors. During LTP induction, the activation of NMDA receptors directs the rapid insertion of AMPA receptors into the postsynaptic density, functionally unsilencing the synapse and establishing active excitatory transmission.
  • Structural Transitions of Gating: Cryo-EM studies by Twomey, Gouaux, and colleagues (2016–2019) resolved the resting, pre-open, open, and desensitized states of GluA2 tetramers. Their structural models demonstrated that glutamate binding triggers a clamshell-like closure of the ligand-binding core domain (composed of D1 and D2 lobes). This structural shift exerts mechanical tension on the linkers connected to the M3 transmembrane helices, pulling them radially outward to open the central ion pore. Desensitization occurs when the D1 dimer interface ruptures, relaxing the linker tension and allowing the channel gate to snap shut even while glutamate remains bound.
  • Receptor Mobility and Lateral Diffusion: Single-particle tracking and fluorescence recovery after photobleaching (FRAP) experiments, spearheaded by Daniel Choquet and colleagues, revealed that AMPA receptors move continuously via lateral diffusion in the plane of the plasma membrane. Rather than remaining rigidly anchored, receptors alternate between a freely diffusing extrasynaptic pool and a transiently immobilized postsynaptic pool. During synaptic stimulation, increased intracellular calcium immobilizes moving receptors directly at the postsynaptic density through interactions with sub-synaptic scaffolds, providing a swift mechanism for scaling synaptic strength.

12. Cultural & Cross-Cultural Considerations

While the biophysical architecture of the AMPA receptor is conserved across all human populations, cultural and systemic factors influence the application and translation of AMPAR-directed research:

  • Global Access to Precision Neurotherapeutics: The development of targeted AMPA receptor modulators, including third-generation non-competitive antagonists and specific positive allosteric modulators, relies heavily on high-resource clinical pipelines. Disparities in access to specialized neurological diagnostics and novel medications mean that costly treatments like perampanel remain out of reach in many developing regions, where older, broader anticonvulsants are used instead.
  • Bioethical Debates on Cognitive Enhancement: The development of ampakines and cognitive-enhancing compounds raises significant cross-cultural and bioethical questions regarding the elective use of “smart drugs” (nootropics) by healthy individuals. Societal perspectives on chemical cognitive enhancement differ markedly across legal and cultural frameworks, shaping varying regulatory policies across North America, Europe, and Asia.

13. Criticisms, Debates & Limitations

Despite significant empirical advancements, several conceptual controversies and methodological challenges remain in AMPA receptor research:

  • Therapeutic Window versus Global Toxicity: A recurring challenge in developing AMPA receptor antagonists has been balancing neuroprotection with acute neurological side effects. Because AMPA receptors mediate the overwhelming bulk of baseline excitatory transmission, fully blocking their activity causes profound sedation, motor ataxia, memory disruption, and psychosis. Early competitive antagonists, such as NBQX, failed in clinical trials due to low solubility, nephrotoxicity, and severe central nervous system depression, shifting modern focus toward subunit-specific and allosteric modulatory strategies.
  • The Subunit Dominance Debate: A long-standing debate centers on the exact subunit requirements for hippocampal LTP. While the classical model posited that GluA1 is mandatory for LTP, knockout mouse studies (such as Gria1 knockout models) revealed that residual, late-onset LTP can still occur via GluA2/GluA3 heteromers or homomeric assemblies under specific stimulation conditions. This finding challenged simple linear models of receptor insertion and highlighted the functional redundancies within synaptic machinery.
  • Isolation of Recombinant versus Native Complexes: Historical conclusions derived from simplified, recombinant systems in non-neuronal cells (such as HEK293 lines) often failed to predict the behavior of native receptors in brain tissue. The discovery that native AMPA receptors are assembled with varying combinations of auxiliary subunits (TARPs, cornichons, and GSG1L) showed that recombinant tetramers lack the authentic kinetic profiles, pharmacology, and gating dynamics found in vivo, prompting a reevaluation of historical pharmacological data.

14. Related Terms & Distinctions

To contextualize the AMPA receptor, it is essential to distinguish it from related ionotropic and metabotropic glutamate receptor families:

  • NMDA Receptor (NMDAR): An ionotropic glutamate receptor permeable to Ca2+, Na+, and K+. Unlike the AMPA receptor, the NMDA receptor requires the simultaneous binding of both glutamate and glycine (or D-serine) and is blocked by extracellular Mg2+ at resting membrane potentials. It operates primarily as a coincidence detector with slower kinetics, rather than the primary driver of baseline fast depolarization.
  • Kainate Receptor: An ionotropic glutamate receptor composed of GluK1 through GluK5 subunits that is activated by kainic acid. Kainate receptors display slower deactivation kinetics than AMPA receptors, can operate through non-canonical metabotropic signaling cascades, and are distributed pre- and postsynaptically to modulate neurotransmitter release rather than executing bulk excitatory transmission.
  • Metabotropic Glutamate Receptors (mGluRs): G-protein coupled receptors (mGluR1 through mGluR8) that respond to glutamate by triggering intracellular second-messenger cascades (such as IP3/DAG or cyclic AMP) rather than opening an intrinsic ion-conduction channel. Their signaling acts over seconds to minutes, modulating synaptic function rather than mediating millisecond-level postsynaptic potentials.
  • GABAA Receptor: A ligand-gated ion channel that mediates fast synaptic transmission, but is activated by γ-aminobutyric acid (GABA) and selectively conducts chloride (Cl−) anions. It serves as the primary mediator of synaptic inhibition, directly opposing the depolarizing excitatory actions of the AMPA receptor.

15. Summary / Key Takeaways

The AMPA receptor is the primary molecular driver of fast, millisecond-scale excitatory neurotransmission in the vertebrate central nervous system. As a ligand-gated ion channel assembled from four core subunits (GluA1–GluA4) and diverse auxiliary proteins, it converts presynaptic glutamate release into rapid postsynaptic membrane depolarization. The post-transcriptional editing of the GluA2 subunit serves as a critical regulatory switch, rendering heterotetrameric receptors impermeable to calcium and protecting neurons from excitotoxicity. Through regulated vesicular exocytosis, endocytosis, and lateral membrane diffusion, AMPA receptors undergo continuous structural and functional reorganization at the postsynaptic density. This dynamic trafficking represents the principal physical mechanism underlying long-term potentiation and depression, linking the biophysics of a single channel directly to learning, memory formation, and the pathophysiology of diverse neurological disorders.

In conclusion, our evolving understanding of the AMPA receptor—progressing from basic pharmacological identification to atomic-resolution cryo-electron microscopy—highlights its central role in modern neurobiology. Ongoing research targeting subunit-specific sites and auxiliary protein interfaces holds strong promise for developing precise, targeted therapeutics that can modulate aberrant neural signaling while preserving baseline synaptic function.

References

Cite This Article

memjavad (2026, October 7). AMPA Receptor: Engine of Synaptic Plasticity. PSYCHOLOGICAL DATABASE. https://en.arabpsychology.com/dictionary/ampa-receptor/
memjavad. “AMPA Receptor: Engine of Synaptic Plasticity.” PSYCHOLOGICAL DATABASE, 7 October 2026, https://en.arabpsychology.com/dictionary/ampa-receptor/.
memjavad. “AMPA Receptor: Engine of Synaptic Plasticity.” PSYCHOLOGICAL DATABASE. October 7, 2026. https://en.arabpsychology.com/dictionary/ampa-receptor/.